Sign in
Stories
Avenova-branded Products in EU Market
Share
Competition Key to Address Drug Shortage...
Decongestants Found to be Useless, Eye D...
Growing Markets for Pain Relief
ANJESO Drug Insight and Market Forecast
AscellaHealth Forecasts Robust Outlook f...
Axsome's FDA Setback Sparks Investigatio...
Overview
API
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals have joined forces to market Avenova-branded products in the European Union through Sonoma's extensive distributor network. The new products will combine Sonoma's existing eye product Ocudox with Avenova branding and are expected to target the treatment and symptoms of blepharitis on the eyelid.
Ask a question
How might the collaboration between NovaBay and Sonoma impact the competitive landscape in the European Union?
What potential benefits could the expansion of Avenova-branded products into the European Union bring to patients and healthcare professionals?
What strategies could Sonoma employ to ensure the success of the new products in the European market?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage